Pfizer Sees a Modest Increase in Trading Activity

1 min read | September 28, 2024 12:15 AM PDT | By Team Kalkine Media

Google News:

Pfizer Sees a Modest Increase in Trading Activity — Image source: Shutterstock

Recent News

Why is Marathon Petroleum (NYSE:MPC) moving with S&P 500 Energy?

Why AbbVie (NYSE:ABBV) Gains in S&P 500 Index Biopharma Push?

Why FactSet Research Systems Anchors Index Stability Gains Now?

Why Is M&T Bank Driving S&P 500 Index Regional Banking Strength?

Make Kalkine Media
My Trusted Source

Headlines

Pfizer's stock price saw a slight uptick in Friday's trading session.

Recent analyst ratings suggest mixed views on Pfizer, with some upgrades and price target adjustments.

Trading volume for Pfizer decreased significantly compared to its average session.

Shares of Pfizer (NYSE:PFE) experienced a modest rise during trading on Friday, reaching a higher level and closing slightly above its previous price. Despite this upward movement, the trading volume was considerably lower than usual.

Analysts have recently shared their perspectives on Pfizer, resulting in mixed reviews. Daiwa Capital Markets upgraded the company’s status from neutral to outperform, increasing its price target. StockNews.com also upgraded Pfizer, and UBS Group adjusted its price objective, maintaining a neutral stance. Similarly, Wells Fargo & Company raised its target price for Pfizer, giving the stock an equal weight rating.

Analyst sentiment shows varying levels of optimism, with some experts providing more favorable assessments of the company's potential. Despite differing opinions, Pfizer continues to attract attention in the market due to its strategic movements and adjusted ratings.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.